As a growing body of research points to the potential for cannabis as a catalyst for climax, WH asks if this is the year that ...

Yeezy isn’t the only company being called out for its “bait-and-switch” Super Bowl commercial, a Californian company called ...

RR reader Liam Maynard feels that the thorny issue of Sunderland’s home attendances is something that can’t be ignored. Got ...

Various big-name stocks made significant moves this week. Here are some of the names that stood out: Intel (NASDAQ: INTC) ...

THE Welsh Open is closing in on a thrilling finale in Llandudno – and the four semi-finalists are now confirmed! Former world ...

U.K.-based ad agency DAIVID said Pfizer had a strong, positive message with its ad and scored high with intense positive emotions. The commercial was also a top performer with spikes in positive ...

We recently published a list of 10 Firms Post Double-Digit Gains on Thursday. In this article, we are going to take a look at ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less alcohol. A study published in JAMA Psychiatry enrolled 48 ...

Snoop Dogg and Tom Brady faced off for a Foundation to Combat Antisemitism Super Bowl ad, spewing hateful phrases during ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

Hims & Hers' future growth is expected from personalized solutions, with potential to expand the subscriber base by millions.

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...